Compagnie Lombard Odier SCmA’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,667
| Closed | -$12.1K | – | 601 |
|
|
2023
Q3 | $12.1K | Hold |
1,667
| – | – | ﹤0.01% | 508 |
|
|
2023
Q2 | $15.6K | Hold |
1,667
| – | – | ﹤0.01% | 487 |
|
|
2023
Q1 | $27.5K | Hold |
1,667
| – | – | ﹤0.01% | 498 |
|
|
2022
Q4 | $45K | Hold |
1,667
| – | – | ﹤0.01% | 484 |
|
|
2022
Q3 | $88K | Buy |
1,667
+667
| +67% | +$35.2K | ﹤0.01% | 405 |
|
|
2022
Q2 | $90K | Hold |
1,000
| – | – | ﹤0.01% | 391 |
|
|
2022
Q1 | $86K | Hold |
1,000
| – | – | ﹤0.01% | 390 |
|
|
2021
Q4 | $92K | Buy |
1,000
+500
| +100% | +$46K | ﹤0.01% | 443 |
|
|
2021
Q3 | $101K | Hold |
500
| – | – | ﹤0.01% | 429 |
|
|
2021
Q2 | $233K | Buy |
+500
| New | +$233K | 0.01% | 323 |
|